Skip to content Skip to sidebar Skip to footer

Anne Li                                                                                                March 25th, 2017

 

Listen below to find out the opinions of Robert A. Figlin, kidney cancer specialist at  Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Eric Jonasch, MD at University of Texas MD Anderson Cancer Center, Toni K. Choueiri, MD at Dana-Farber Cancer Institute, Michael R. Harrison, MD at Duke Cancer Institute, and David I. Quinn, MBBS and PhD from USC Norris Cancer Hospital on the future of therapy goals for advanced kidney cancer.

 

See original article at: https://www.onclive.com/peer-exchange/advanced-kidney-cancer/goals-of-therapy-for-advanced-kidney-cancer

Leave a comment